
Biotage launches new automated platform for plasmid DNA purification
pharmafile | June 22, 2021 | News story | Manufacturing and Production |
Biotage has launched PhyPrep, a new automated platform for plasmid DNA purification.
With the new Biotage PhyPrep platform, the automated process purifying plasmid DNA reduces the risk of human error.
Additionally, because the sample is being handled in the same way, the plasmid yield and purities are more consistent.
Plasmid DNA, or simply plasmids, serve as important tools in life science and biotechnology industry and academic laboratories. Plasmids are commonly used to clone and amplify, or express particular genes. A wide variety of plasmids are commercially available for such uses.
Plasmids are commonly being used in drug discovery and development for biopharmaceuticals.
Tomas Blomquist, Biotage CEO, said: “The launch of the Biotage® PhyPrep will assist laboratories in discovering new therapies for patients, utilizing biological drug molecules such as antibodies and novel gene therapies.
“A perfect match with the Biotage ethos of “HumanKind Unlimited” – sustainably releasing the potential of science to address the issues faced by global society, making the world healthier, greener and cleaner.”
Biotage® PhyPrep is the first automated solution for plasmid purification in Maxi, Mega and Giga scales. The various scales differ in the volume of cell culture to be purified, with desired yields ranging from 1 mg to 10 mg of plasmid DNA.
Lilly Subbotin






